CLINICAL RESEARCH
Gender differences in efficiency of the telemedicine care of heart failure patients. The results from the TeleEduCare-HF study
More details
Hide details
1
Department of Cardiology and Adult Congenital Heart Diseases, Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
2
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Poland
3
University of Lodz, Poland
4
Sukhumi State University, Tbilisi, Georgia
5
Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
6
Department of Medical Biotechnology, Medical University of Lodz, Poland
Submission date: 2024-01-30
Acceptance date: 2024-01-31
Online publication date: 2024-12-31
Corresponding author
Agata Bielecka-Dąbrowa
Department of Cardiology
and Adult Congenital
Heart Diseases
Polish Mother’s
Memorial Hospital
Research Institute
Rzgowska 281/289
93-338 Lodz, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim of this study was to implement a model of healthcare for patients with heart failure (HF) and to assess the differences between men and women in the study population.
Material and methods:
Through care and an extensive educational panel (dietary recommendations, physical activity, titration of diuretics, psychological support), emphasis was placed on prevention. All patients had a baseline cardiology consultation with recommendations regarding treatment, self-care, diet, and exercise. Based on regular measurements of weight and blood pressure HF patients were telemonitored by nurses, primary care physicians and referred to cardiologists when necessary. The questionnaire was conducted in all patients at baseline after enrollment to the study and after 3 months of telemonitoring and extensive educational process.
Results:
The study finally included 140 men with an average age of 66 years (SD: 56–71) and 163 women with an average age of 64 years (58–72). The ischemic origin of HF was present in 78% of men and 73% of women (p = 0.40), and 31% of men and 16% of women declared myocardial infarction in the past (p = 0.002). Men more often survived sudden cardiac arrest (7.8% vs. 1.2%; p = 0.004) and had implantable cardiac devices compared to women (16% vs. 3%; p = 0.001). Male patients reported significantly more often alcohol consumption, smoking, and less frequently any physical activity. Women significantly more often than men suffered from cancer, depression, and thromboembolic events and less frequently from obstructive sleep apnea. The mean left ventricular ejection fraction (LVEF) was 43% (SD: 30–58) for men, and 57% (45–63) for women (p = 0.0001), and women suffered mainly from heart failure with preserved ejection fraction. There were no differences between genders regarding the number of hospitalizations in last 12 months. The men, despite lower LVEF, felt short of breath/tired when climbing the stairs up than women (3 [2–4] vs. 2 floors [1–3]; p = 0.001), had higher distance in meters when walking on flat ground (400 [200–400] vs. 300 m [100–400]; p = 0.0001), and less frequently had to get up to go to the toilet at night (p = 0.03). Men also suffered significantly less often from shortness of breath at rest, swelling of the lower limbs and shortness of breath that wakes them up at night. Only 35% of men and 19% of women had HF self-care training, and only 35% of men and 46% of women knew how to increase the dose of diuretic on their own if shortness of breath or swelling increases. Based on the EuroQol-5 dimensions 5-levels questionnaire, significantly more women than men reported moderate and serious problems with moving around, serious problems with performing ordinary activities independently as well as moderate and serious pain problem and a significant level of anxiety. Men more often than women reported serious problems with self-care.
Conclusions:
Women suffer more often from HF symptoms and have worse quality of life assessed in EQ-5D-5L than men despite their higher LVEF.
REFERENCES (49)
1.
Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-46.
2.
Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation 2016; 133: e38-360.
3.
Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 3068-72.
4.
Ponikowski P, Voors A, Anker S, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016; 33: 1787-847.
5.
OECD 2015 Avoidable hospital admissions in Health AT a Glance 2015: OECD Indicators. OECD Publishing. Paris. doi:10.1787/health_glance-2015-en.
6.
Karasek D, Kubica A, Sinkiewicz W, Błażejewski J, Bujak R. Epidemia niewydolności serca – problem zdrowotny i społeczny starzejących się społeczeństw Polski i Europy. Folia Cardiol Excer 2008; 3: 242-8.
7.
Rywik TM, Kolodziej P, Targonski R, et al. Characteristics of the heart failure population in Poland: ZOPAN, a multicentre national programme. Kardiol Pol 2011; 69: 24-31.
8.
Rywik TM, Zielinski T, Piotrowski W, et al. Heart failure patients from hospital settings in Poland: population characteristics and treatment patterns, a multicenter retrospective study. Cardiol J 2008; 15: 169-80.
9.
Balsam P, Tyminska A, Kaplon-Cieslicka A, et al. Predictors of one-year outcome in patients hospitalized for heart failure: results from the Polish part of the Heart Failure Pilot Survey of the European Society of Cardiology. Kardiol Pol 2016; 74: 9-17.
10.
Mapa potrzeb zdrowotnych w zakresie kardiologii dla Polski. Secondary [Mapping health needs in cardiology for Poland] Mapa potrzeb zdrowotnych w zakresie kardiologii dla Polski 2019.
http://mpz.mz.gov.pl/wp-conten....
11.
Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123-33.
12.
Sytuacja Zdrowotna Ludności Polski, Narodowy Instytut Zdrowia Publicznego 2022.
13.
McDonagh T, Metra M, Adamo M et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021; 42: 3599-726.
14.
Krówczyńska D, Jankowska-Polańska B. Polish nurses’ knowledge of heart failure self-management principles. Int J Environ Res Public Health 2022; 19: 1327.
15.
Finkelstein SN, Levy RI, Moskowitz J, Roberts EB, Sondik EJ. Biomedical innovation: the challenge and the practice, MIT Sloan School of Management, Cambridge 1981, June, s. 1-22 (working paper).
16.
Marcolino MS, Alkmim MBM, e Silva MVRS., et al. Telecardiology. [In:] Telehealth and Mobile Health. Eren H, Webster JG (eds.). CRC Press., Boca Raton 2017; 379-400.
17.
Bolerion A. AI in Healthcare. The Future of Savings Lives, Amazon 2023.
18.
Coravos A, Goldsack DR, Nebeker C, Perakslis E, Zimmerman N, Erb MK. Digital Medicine Measurement. Karger Publisher Ltd., Oxford 2020.
19.
Cuyled R, Holland D. Implementing Telemedicine. Completing Projects on Target on Time on Budget, Xlibris, e-book. 2012.
20.
Vuèkovic I, Dilberovic F, Kapur E, Voljevica A, Bilalovic N, Selak I. The principles of telemedicine in practice. Bosnian J Basic Med Sci 2003; 3: 54-60.
21.
World Health Organization 2009, Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth, Global Observatory for eHealth series, Vol 2.
23.
Frazier CG, Alexander KP, Newby LK, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol 2007; 49: 1450-8.
24.
Parashar S, Katz R, Smith NL, et al. Race, gender and mortality in adults ≥65 years of age with incident heart failure (from the Cardiovascular Health Study). Am J Cardiol 2009; 103: 1120-7.
25.
Orzechowski P, Piotrowicz R, Zareba W, et al. Antiarrhythmic effect of 9-week hybrid comprehensive telerehabilitation and its influence on cardiovascular mortality in long-term follow-up – subanalysis of the TELEREHabilitation in Heart Failure Patients randomized clinical trial. Arch Med Sci 2022; 18: 293-306.
26.
Piotrowicz E, Pencina MJ, Opolski G, et al. Effects of a 9-week hybrid comprehensive telerehabilitation program on long-term outcomes in patients with heart failure: the telerehabilitation in heart failure patients (TELEREH-HF) randomized clinical trial. JAMA Cardiol 2020; 5: 300-8.
27.
Sabouret P, Lemesle G, Bellemain-Appaix A, et al. Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper. Arch Med Sci 2022; 18: 839-54.
28.
Yeung AWK, Torkamani A, Butte AJ, et al. The promise of digital healthcare technologies. Front Public Health 2023; 11: 1196596.
29.
Umeh CA, Reddy M, Dubey A, Yousuf M, Chaudhuri S, Shah S. Home telemonitoring in heart failure patients and the effect of study design on outcome: a literature review. J Telemed Telecare 2021; 30: 44-52.
30.
Frederix I, Vanderlinden L, Verboven A, et al. Long-term impact of a six-month telemedical care programme on mortality, heart failure readmissions and healthcare costs in patients with chronic heart failure. J Telemed Telecare 2018; 25: 286-93.
31.
Cleland JGF, Clark RA, Pellicori P, Inglis SC. Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic: the advantages of universal access to home telemonitoring. Eur J Heart Fail 2020; 22: 995-8.
32.
Brons M, Koudstaal S, Asselbergs F. Algorithms used in telemonitoring programmes for patients with chronic heart failure: a systematic review. Eur J Cardiovasc Nurs 2018; 17: 580-8.
33.
Zavertnik J. Self-care in older adults with heart failure. Clin Nurse Spec 2014; 28: 19-32.
34.
Lin H, Kwan A, Castro-Diehl C, et al. Sex-specific differences in the genetic and environmental effects on cardiac phenotypic variation assessed by echocardiography. Sci Rep 2023; 13: 5786.
35.
Gori M, Lam C, Gupta D, et al. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail 2014; 16: 535-42.
36.
Meyer S, Meer P, Massie B, et al. Sex-specific acute heart failure phenotypes and outcomes from protect. Eur J Heart Fail 2013; 15: 1374-81.
37.
Frankenstein L, Clark A, Ribeiro J. Influence of sex on treatment and outcome in chronic heart failure. Cardiovasc Ther 2011; 30: 182-92.
38.
Stockdill M, Patrician P, Bakitas M. Understanding and measuring symptom burden in heart failure: a concept analysis. West J Nurs Res 2019; 41: 1423-47.
39.
Wang Y. Psychosomatic mechanisms of heart failure symptoms on quality of life in patients with chronic heart failure: a multi-centre cross-sectional study. J Clin Nurs 2023; 33: 1839-48.
40.
Barsheshet A, Brenyo A, Goldenberg I, Moss A. Sex-related differences in patients’ responses to heart failure therapy. Nat Rev Cardiol 2012; 9: 234-42.
41.
Mei J, Tian Y, Chai X, Fan X. Gender differences in self-care maintenance and its associations among patients with chronic heart failure. Int J Nurs Sci 2019; 6: 58-64.
42.
Bidwell JT, Vellone E, Lyons KS, et al. Determinants of heart failure self-care maintenance and management in patients and caregivers: a dyadic analysis. Res Nurs Health 2015; 38: 392-402.
43.
Bikiewicz A, Banach M, von Haehling S, Maciejewski M, Bielecka-Dabrowa A. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications. ESC Heart Fail 2021; 8: 2397-18.
44.
Tyebally S, Sia CH, Chen D, et al. The intersection of heart failure and cancer in women: a review. Front Cardiovasc Med 2024; 11: 1276141.
45.
Ryczkowska K, Adach W, Janikowski K, Banach M, Bielecka-Dabrowa A. Menopause and women’s cardiovascular health: is it really an obvious relationship? Arch Med Sci 2022; 19: 458-66.
46.
Valenzuela-Rodriguez G, Diaz-Arocutipa C, Collins JA, Lopez-Fernandez T, Gomez HL, Hernandez AV. Severe cardiac events induced by combination immunotherapy in patients with cancer: a meta-analysis. Arch Med Sci 2023; 19: 1662-70.
47.
Abdel-Qadir H, Thavendiranathan P, Austin PC, et al. The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study. JNCI 2019; 111: 854-62.
48.
Han X, Liu F, Hidru TH, et al. Postmenopausal women with breast, endometrial, and ovarian cancers have an increased risk for cardiovascular conditions prior to active endocrine therapy. Oxid Med Cell Longev 2022; 2022: 5104351.
49.
Lam PH, Barac A, Nohria A, et al. Temporal associations and outcomes of breast cancer and heart failure in postmenopausal women. JACC Cardiooncol 2020; 2: 567-77.